HomeAbout

TL;DR CNBC


As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data - TL;DR CNBC

As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data

Publishing timestamp: 2023-10-24 06:00:01


Summary

Wearable startup Signos has closed a $20 million funding round led by Cheyenne Ventures and GV. The company's platform uses data from continuous glucose monitors (CGMs) to provide real-time diet and exercise recommendations for weight loss. Signos aims to help individuals understand their metabolism and make better choices for their bodies. The funding will be used to continue research into metabolic health and expand the team.


Sentiment: NEUTRAL

Tickers: DXCMAAPLNOVO.B-DKGOOGLABT

Keywords: health care industrynovo nordisk a/sabbott laboratoriestechnologybreaking news: technologyweight managemententerprisedexcom incalphabet incbusiness newsapple inc

Source: https://www.cnbc.com/2023/10/24/signos-raised-20-million-to-tackle-weight-loss-with-cgms-and-data.html


Developed by Leo Phan